Vesselon, Inc.
Patentable drug co-formulations using biophysically activated lipid microspheres and self-assembling liposomes to enhance drug efficacy and tissue targeting
- Sector
- Biotech
- Headquarters
- Norwalk, CT
- Founded
- 2012
- Latest Form D
- $150K, Jul 2016
- Total capital
- $1.3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.3M
- 4 Form D · last Jul 2016
- 124 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 7 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$150K
- Private capital raisedForm D · SEC · 3rd filing$75K
- Private capital raisedForm D · SEC · 2nd filing$1M
- Private capital raisedForm D · SEC · 1st filing$100K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Clay LarsenExecutive Officer, DirectorNamed in SEC Form D filings
- Clayton T LarsenExecutive Officer, DirectorNamed in SEC Form D filings
- Jon C SerbousekDirectorNamed in SEC Form D filings
- Jurgen RathsDirectorNamed in SEC Form D filings
- Kevin KimberlinDirectorNamed in SEC Form D filings
- Paul LatchfordDirectorNamed in SEC Form D filings
Show all 8 people
- Paul S. Latchford, Jr.DirectorNamed in SEC Form D filings
- Rhodemann LiExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 7- PendingCompositions And Methods For Targeted Delivery Of Therapeutics Using CarriersUSPTOApplication 18457915
- PendingCompositions And Methods For Targeted Delivery Of Therapeutics Using CarriersUSPTOApplication 17743056
- PendingAutomated Ultrasound Apparatus And Method For Noninvasive Vessel Recanalization Treatment And MonitoringUSPTOApplication 15536482
Show all 7 patent records
- Compositions And Methods For Targeted Delivery Of Therapeutics Using CarriersDec 28, 2023 · Application 18457915Pending
- Compositions And Methods For Targeted Delivery Of Therapeutics Using CarriersFeb 23, 2023 · Application 17743056Pending
- Automated Ultrasound Apparatus And Method For Noninvasive Vessel Recanalization Treatment And MonitoringJan 4, 2018 · Application 15536482Pending
- Automated Ultrasound Apparatus And Method For Noninvasive Vessel Recanalization Treatment And MonitoringApplication 62091916Pending
- Novel Compositions And Methods For Targeted Delivery Of Therapeutics Using CarriersApplication 63109193Pending
- Compositions And Methods For Targeted Delivery Of Therapeutics Using CarriersApplication PCTUS2021057961Pending
- Automated Ultrasound Apparatus And Method For Noninvasive Vessel Recanalization Treatment And MonitoringApplication PCTUS2015065837Pending
Related companies, and why
- Koniku Inc.Similar federal contract value in Biotech · null in contracts
- Bakhu Holdings, Corp.Similar federal contract value in Biotech · null in contracts
- Stork Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- HELUS, INC.Similar federal contract value in Biotech · null in contracts
- Orbsen Therapeutics Ltd.Similar federal contract value in Biotech · null in contracts
- EMMAUS MEDICAL INCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .